CRISPR Therapeutics AG
NASDAQCRSP heads into its May 11 earnings report carrying one of the most crowded short positions in biotech — and fresh evidence that options traders turned meaningfully more defensive this week. The options signal is the sharpest development. The put/call ratio jumped to 0.64 on Tuesday, more than 2.5 standard deviations above its 20-day average of 0.55. That is the highest reading of…
Snapshot as of 7 May 2026
CRSP heads into its May 11 earnings report carrying one of the most crowded short positions in biotech — and fresh evidence that options traders turned meaningfully more defensive this week. The options signal is the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRSP — free to start on ORTEX.
Sign up for free →Open CRSP on ORTEX